AbstractHypertriglyceridemia is one of the most common lipid abnormalities encountered in clinical practice. Many monogenic disorders causing severe […]
A former doctor who ran two US contract research companies has been imprisoned for 28 years for faking […]
Mathematical simulation models play an important role in evaluating the course of an epidemic or pandemic in a […]
Dovato demonstrated non-inferior efficacy compared to TAF-based regimens
Oral S1P receptor modulator hit both primary endpoints in a phase III trial
Therapy failed to improve invasive disease-free survival in high-risk patients
Two trials will involve over 6,000 participants at sites in and outside the US
Bristol Myers Squibb’s Zeposia boosts remission rates over placebo in ulcerative colitis patients kblankenship Fri, 10/09/2020 – 13:50
Virologists have shown that a treatment with the anti-malaria drug hydroxychloroquine does not limit SARS-CoV-2 coronavirus replication in […]
Researchers used a second-generation pro-drug called MP-Pt(IV) to target the deadly cells of glioblastoma tumors and found mice […]